BDCRB (Glaxo/Univ of Michigan)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBDCRB (Glaxo/Univ of Michigan)
Drug Alias NameFTCRI nucleosides (GlaxoSmithKline/University of Michigan)toyocamycin analogsTCRB analogs (Glaxo)BDCRBUDJO-1325 +[6] 
ClassificationSmall molecules
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MichiganGlaxo Group Ltd
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A